Kang Ho Kim1, Sungwoo Choi2, Ying Zhou1,3, Eun Young Kim4, Jae Man Lee4, Pradip K Saha1, Sayeepriyadarshini Anakk5, David D Moore1,2,3. 1. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX. 2. Program in Developmental Biology, Baylor College of Medicine, Houston, TX. 3. Integrative Molecular and Biomedical Sciences Graduate Program, Baylor College of Medicine, Houston, TX. 4. Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea. 5. Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL.
Abstract
The nuclear receptors farnesoid X receptor (FXR; NR1H4) and small heterodimer partner (SHP; NR0B2) play crucial roles in bile acid homeostasis. Global double knockout of FXR and SHP signaling (DKO) causes severe cholestasis and liver injury at early ages. Here, we report an unexpected beneficial impact on glucose and fatty acid metabolism in aged DKO mice, which show suppressed body weight gain and adiposity when maintained on normal chow. This phenotype was not observed in single Fxr or Shp knockouts. Liver-specific Fxr/Shp double knockout mice fully phenocopied the DKO mice, with lower hepatic triglyceride accumulation, improved glucose/insulin tolerance, and accelerated fatty acid use. In both DKO and liver-specific Fxr/Shp double knockout livers, these metabolic phenotypes were associated with altered expression of fatty acid metabolism and autophagy-machinery genes. Loss of the hepatic FXR/SHP axis reprogrammed white and brown adipose tissue gene expression to boost fatty acid usage. CONCLUSION: Combined deletion of the hepatic FXR/SHP axis improves glucose/fatty acid homeostasis in aged mice, reversing the aging phenotype of body weight gain, increased adiposity, and glucose/insulin tolerance, suggesting a central role of this axis in whole-body energy homeostasis. (Hepatology 2017;66:498-509).
The nuclear receptors farnesoid X receptor (FXR; NR1H4) and small heterodimer partner (SHP; NR0B2) play crucial roles in bile acid homeostasis. Global double knockout of FXR and SHP signaling (DKO) causes severe cholestasis and liver injury at early ages. Here, we report an unexpected beneficial impact on glucose and fatty acid metabolism in aged DKO mice, which show suppressed body weight gain and adiposity when maintained on normal chow. This phenotype was not observed in single Fxr or Shp knockouts. Liver-specific Fxr/Shp double knockout mice fully phenocopied the DKO mice, with lower hepatic triglyceride accumulation, improved glucose/insulin tolerance, and accelerated fatty acid use. In both DKO and liver-specific Fxr/Shp double knockout livers, these metabolic phenotypes were associated with altered expression of fatty acid metabolism and autophagy-machinery genes. Loss of the hepatic FXR/SHP axis reprogrammed white and brown adipose tissue gene expression to boost fatty acid usage. CONCLUSION: Combined deletion of the hepatic FXR/SHP axis improves glucose/fatty acid homeostasis in aged mice, reversing the aging phenotype of body weight gain, increased adiposity, and glucose/insulin tolerance, suggesting a central role of this axis in whole-body energy homeostasis. (Hepatology 2017;66:498-509).
Authors: Rucha Patel; Angie L Bookout; Lilia Magomedova; Bryn M Owen; Giulia P Consiglio; Makoto Shimizu; Yuan Zhang; David J Mangelsdorf; Steven A Kliewer; Carolyn L Cummins Journal: Mol Endocrinol Date: 2014-12-11
Authors: Jiansheng Huang; Jahangir Iqbal; Pradip K Saha; Jun Liu; Lawrence Chan; M Mahmood Hussain; David D Moore; Li Wang Journal: Hepatology Date: 2007-07 Impact factor: 17.425
Authors: Jae Man Lee; Martin Wagner; Rui Xiao; Kang Ho Kim; Dan Feng; Mitchell A Lazar; David D Moore Journal: Nature Date: 2014-11-12 Impact factor: 49.962
Authors: Sung Ho Lee; Jong Min Choi; Sung Yun Jung; Aaron R Cox; Sean M Hartig; David D Moore; Kang Ho Kim Journal: Biochem Biophys Res Commun Date: 2020-11-07 Impact factor: 3.575
Authors: Derek J Erstad; Christian T Farrar; Sarani Ghoshal; Ricard Masia; Diego S Ferreira; Yin-Ching Iris Chen; Ji-Kyung Choi; Lan Wei; Phillip A Waghorn; Nicholas J Rotile; Chuantao Tu; Katherine A Graham-O'Regan; Mozhdeh Sojoodi; Shen Li; Yang Li; Guogiang Wang; Kathleen E Corey; Yat Sun Or; Lijuan Jiang; Kenneth K Tanabe; Peter Caravan; Bryan C Fuchs Journal: Hepatol Commun Date: 2018-05-21